Dot gov

Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

A-5. Documents

HHSC publishes the following documents on the VDP website Agendas and Documents page (txvendordrug.com/resources/drug-utilization-review-board/agendas-and-documents):

  • Yearly Tentative Drug Class Review
    • At the end of each calendar year, HHSC publishes a tentative schedule of the drug classes planned for review at each year’s DUR board meetings. HHSC establishes the schedule and accounts for various seasonal health conditions, such as influenza
  • Quarterly Tentative Drug Class Review
    • Identifies drug classes on the Yearly Tentative Drug Class Review Schedule proposed for review at the next quarterly DUR board meeting. Published before each Texas Drug Utilization Review Board meeting
  • Agenda
    • HHSC publishes the board agenda of all drugs and drug classes for review 10-to-15 days before the meeting date.
  • Meeting summary
    • HHSC publishes a review of the meeting within 10 business days, including links to the webcast and previous meeting’s minutes, as well as clinical prior authorization and preferred drug list updates
  • Meeting minutes
    • The board reviews and approves the minutes of the previous meeting.
    • Approved meeting minutes are available upon request to the HHSC Open Records Coordinator.
  • Preferred Drug List Recommendations
    • The board recommends drugs and drug classes for inclusion to the PDL based on clinical, financial, and safety at each board meeting. HHSC publishes a list of the recommendations within 10 business days after each meeting.
  • Preferred Drug List Decisions
    • The Texas HHSC Executive Commissioner reviews and approves the list of recommended PDL changes. HHSC publishes the list of the approved decisions on the Vendor Drug Program website 2-3 months after each meeting.